Bioverativ Presents Updates on Treatments and Research for Sickle Cell Anemia and Hemophilia
Cozendo / Pixabay

Bioverativ Presents Updates on Treatments and Research for Sickle Cell Anemia and Hemophilia

According to a story from Business Wire, the drug developer Bioverativ, Inc., recently announced its intention to present data related to its latest developments in blood disorder therapies. This data…

Continue Reading Bioverativ Presents Updates on Treatments and Research for Sickle Cell Anemia and Hemophilia

New Collaborative Clinical Trial Announced to Test Experimental Urothelial Cancer Treatment

According to a story from PRNewswire, Infinity Pharmaceuticals and the Bristol-Myers Squibb Company recently announced that the two companies will be partnering in order to conduct a Phase 2 clinical…

Continue Reading New Collaborative Clinical Trial Announced to Test Experimental Urothelial Cancer Treatment
Researchers were Wrong about the Cause of Muscular Dystrophy
qimono / Pixabay

Researchers were Wrong about the Cause of Muscular Dystrophy

For a long time, neuromuscular diseases such as muscular dystrophy, ALS, and inclusion body myopathy were thought to be caused as a result of toxic clumps of proteins such as TDP-43.…

Continue Reading Researchers were Wrong about the Cause of Muscular Dystrophy